Home » Topics » Conferences

Conferences
RSS

NNC-126-0083 is well tolerated in adults and children with growth hormone deficiency

Oct. 4, 2010

Phase I investigation of CombiHIVvac HIV vaccine begins

Oct. 4, 2010

EP-017796 is active against drug-resistant bacteria

Oct. 4, 2010

Cationic peptide NP-339 is active against Candida species

Oct. 4, 2010

CMX-001 is not nephrotoxic in patients with viral infections

Oct. 4, 2010

Chitosan-GP is efficacious in ongoing trial in patients with articular cartilage lesions

Oct. 1, 2010

SAR-707 reveals limitations of acyl-CoA desaturase inhibition in metabolic disorders

Oct. 1, 2010

TransVax reduces cytomegalovirus viremia in phase II trial

Oct. 1, 2010

Phase II data show efficacy of Gilead Sciences' Quad anti-HIV regimen through 48 weeks

Oct. 1, 2010

QTc interval is prolonged in myotonic dystrophy type 1 / News in Context

Oct. 1, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...